▲ Peaking
Business
Eli Lilly’s Next Weight-Loss Drug Helped Patients Lose Up to 54 Pounds. Why the FDA’s New Warning Didn’t Hurt LLY Stock.
Eli Lilly’s next weight-loss drug helped patients lose up to 54 pounds, yet the company’s $1.4 trillion valuation carries heavy expectations even after an FDA warning failed to dent its stock.